Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)

Amulya Yellala, Apar Kishor Ganti

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)824-827
Number of pages4
JournalTranslational Lung Cancer Research
Volume9
Issue number3
DOIs
StatePublished - Jun 1 2020

ASJC Scopus subject areas

  • Oncology

Cite this